Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Day: September 3, 2021

Efforts grow to stamp out use of parasite drug for COVID-19 – ABC News,

This week, the top U.S. professional groups for doctors and pharmacists appealed for an “immediate end” to the drug’s use outside of research., This week, the top U.S. professional groups for doctors and pharmacists appealed for an “immediate end” to the drug’s use outside of research., Read More

Psilocybin lawyer asks 9th Circ to weigh workaround to fed drug law | Reuters,

Psilocybin has been the subject of clinical trials to treat terminal patients’ anxiety and depression, but remains a so-called Schedule I substance under …, Psilocybin has been the subject of clinical trials to treat terminal patients’ anxiety and depression, but remains a so-called Schedule I substance under …, Read More

Alpha Cognition Reports Second Quarter of Fiscal 2021 Results – Yahoo Finance,

Research and development expenses were $1.5m for the three months ended June … will advise the company regarding scientific programs and clinical trials., Research and development expenses were $1.5m for the three months ended June … will advise the company regarding scientific programs and clinical trials., Read More

Latest drug treatments and clinical trials to fight COVID-19 – CGTN,

Managing life with the virus will require a multi-pronged approach that includes vaccines, masks and drugs to treat infections. CGTN’s Karina Huber reports., Managing life with the virus will require a multi-pronged approach that includes vaccines, masks and drugs to treat infections. CGTN’s Karina Huber reports., Read More

Scroll to Top